Home versus in-centre haemodialysis for end-stage kidney disease
نویسندگان
چکیده
منابع مشابه
Haemodialysis and Vascular Access in the End Stage Kidney Disease
The efficiency of haemodialysis treatment relies on a functional status of vascular access. A vascular access makes life-saving haemodialysis treatments possible. The efficiency of haemodialysis treatment relies on a functional status of vascular access. The purpose of this review was to discuss the role of haemodialysis and vascular access in end stage kidney disease. Vascular access and its r...
متن کاملHaemodialysis treatment for end stage chronic kidney disease and acute kidney injury in Africa.
Chronic kidney disease (CKD) is the progressive loss of kidney function occurring over months to years. CKD is common in Africa but there are few data on prevalence. Several studies from Africa report a prevalence of CKD of about 10%. Once the glomerular filtration rate (GFR) falls below 10ml/minutes/1.73m the accumulation of uraemic toxins (measured as serum urea and creatinine), hydrogen ions...
متن کاملCardiorenal Syndrome in End-Stage Kidney Disease.
BACKGROUND Cardiorenal syndrome (CRS) in patients with end-stage kidney disease (ESKD) represents mainly cardiovascular disease (CVD) due to various complications associated with renal dysfunction-defined as type 4 CRS by Ronco et al.-because the effect of cardiac dysfunction on the kidneys does not need to be taken into consideration, unlike in non-dialysis dependent chronic kidney disease (CK...
متن کاملCardiorenal Syndrome in End-Stage Kidney Disease
Background: Cardiorenal syndrome (CRS) in patients with end-stage kidney disease (ESKD) represents mainly cardiovascular disease (CVD) due to various complications associated with renal dysfunction—defined as type 4 CRS by Ronco et al.—because the effect of cardiac dysfunction on the kidneys does not need to be taken into consideration, unlike in non-dialysis dependent chronic kidney disease (C...
متن کاملCardiorenal Syndrome in End-Stage Kidney Disease
Background: Cardiorenal syndrome (CRS) in patients with end-stage kidney disease (ESKD) represents mainly cardiovascular disease (CVD) due to various complications associated with renal dysfunction—defined as type 4 CRS by Ronco et al.—because the effect of cardiac dysfunction on the kidneys does not need to be taken into consideration, unlike in non-dialysis dependent chronic kidney disease (C...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2014
ISSN: 1465-1858
DOI: 10.1002/14651858.cd009535.pub2